This guide illustrates potential compliance risks for companies when providing patient support services.

This sub path illustrates potential compliance risks for life science companies when providing patient support, specifically related to HCP reimbursement support.

This sub path illustrates potential compliance risks for life science companies when providing patient support, specifically related to patient benefits and reimbursement support.

This sub path illustrates potential compliance risks for life science companies when providing patient support, specifically related to training healthcare providers (HCPs) on product use.

This sub path illustrates potential compliance risks for life science companies when providing funding to Independent Charity Patient Assistance Programs (ICPAP).

This sub path illustrates potential compliance risks for life science companies when providing patient support services, specifically related to training patients on product use.

Manufacturers of rare disease treatments and gene therapy products face a complex landscape.